Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 11 studies | 56% ± 22% | |
oligodendrocyte | 11 studies | 32% ± 11% | |
adipocyte | 8 studies | 35% ± 14% | |
cardiac muscle cell | 6 studies | 49% ± 18% | |
club cell | 5 studies | 34% ± 13% | |
type II pneumocyte | 5 studies | 35% ± 10% | |
epithelial cell | 4 studies | 23% ± 7% | |
gamma-delta T cell | 4 studies | 20% ± 5% | |
endothelial cell | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 14125.85 | 652 / 653 | 95% | 86.83 | 576 / 605 |
breast | 94% | 1967.15 | 431 / 459 | 95% | 4.06 | 1060 / 1118 |
lung | 99% | 4835.24 | 575 / 578 | 86% | 3.47 | 992 / 1155 |
prostate | 87% | 1395.04 | 213 / 245 | 90% | 2.62 | 453 / 502 |
stomach | 64% | 696.30 | 228 / 359 | 85% | 4.22 | 243 / 286 |
intestine | 56% | 1308.94 | 541 / 966 | 92% | 5.03 | 485 / 527 |
brain | 36% | 369.06 | 952 / 2642 | 77% | 1.72 | 546 / 705 |
skin | 79% | 1313.51 | 1428 / 1809 | 27% | 0.54 | 128 / 472 |
esophagus | 30% | 297.28 | 437 / 1445 | 73% | 2.17 | 133 / 183 |
uterus | 20% | 225.01 | 34 / 170 | 81% | 2.98 | 374 / 459 |
muscle | 100% | 9032.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2131.37 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.56 | 1 / 1 |
heart | 96% | 4638.06 | 830 / 861 | 0% | 0 | 0 / 0 |
pancreas | 11% | 102.55 | 35 / 328 | 85% | 2.38 | 152 / 178 |
bladder | 38% | 412.76 | 8 / 21 | 58% | 2.24 | 292 / 504 |
adipose | 96% | 2147.91 | 1156 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 2.76 | 42 / 45 |
peripheral blood | 89% | 3419.47 | 824 / 929 | 0% | 0 | 0 / 0 |
kidney | 44% | 516.92 | 39 / 89 | 38% | 1.21 | 345 / 901 |
liver | 4% | 34.12 | 9 / 226 | 76% | 2.42 | 309 / 406 |
lymph node | 0% | 0 | 0 / 0 | 76% | 1.48 | 22 / 29 |
ovary | 7% | 55.72 | 13 / 180 | 64% | 1.75 | 276 / 430 |
adrenal gland | 17% | 148.78 | 45 / 258 | 28% | 0.65 | 64 / 230 |
blood vessel | 31% | 352.19 | 415 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.03 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043276 | Biological process | anoikis |
GO_2000424 | Biological process | positive regulation of eosinophil chemotaxis |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0010506 | Biological process | regulation of autophagy |
GO_2001242 | Biological process | regulation of intrinsic apoptotic signaling pathway |
GO_0090023 | Biological process | positive regulation of neutrophil chemotaxis |
GO_0006915 | Biological process | apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0034423 | Cellular component | autophagosome lumen |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
Gene name | DAPK2 |
Protein name | DAPK2 protein Death-associated protein kinase 2 (DAP kinase 2) (EC 2.7.11.1) (DAP-kinase-related protein 1) (DRP-1) Death associated protein kinase 2 |
Synonyms | |
Description | FUNCTION: Calcium/calmodulin-dependent serine/threonine kinase involved in multiple cellular signaling pathways that trigger cell survival, apoptosis, and autophagy. Regulates both type I apoptotic and type II autophagic cell death signals, depending on the cellular setting. The former is caspase-dependent, while the latter is caspase-independent and is characterized by the accumulation of autophagic vesicles. Acts as a mediator of anoikis and a suppressor of beta-catenin-dependent anchorage-independent growth of malignant epithelial cells. May play a role in granulocytic maturation . Regulates granulocytic motility by controlling cell spreading and polarization . .; FUNCTION: Isoform 2 is not regulated by calmodulin. It can phosphorylate MYL9. It can induce membrane blebbing and autophagic cell death. |
Accessions | ENST00000558064.1 ENST00000559306.1 ENST00000561162.5 ENST00000612884.4 [Q9UIK4-2] ENST00000559007.5 ENST00000558069.5 [Q9UIK4-2] H0YL86 H0YMK1 Q1RMF4 Q9UIK4 H0YKW8 ENST00000261891.7 [Q9UIK4-1] H0YLP5 ENST00000457488.6 [Q9UIK4-1] |